This Form 4 filing reports a transaction by James Pursley, President of Hinge Health, Inc. On December 22, 2025, Pursley sold 15,000 shares of Class A Common Stock at a weighted average price of $48.3967 per share. The sale was executed as part of a Rule 10b5-1 trading plan. Following this transaction, Pursley owns 769...

Benjamin Hohl, Chief Financial Officer of Enliven Therapeutics, Inc., reported a transaction on December 22, 2025. He acquired 13,000 shares of Common Stock at a price of $2.48 per share, increasing his post-transaction holdings to 36,000 shares. Additionally, Mr. Hohl exercised a stock option for 13,000 shares of Comm...

Jay C. Horgen, Chief Executive Officer and Director of AFFILIATED MANAGERS GROUP, INC., reported a disposition of 4,000 shares of Common Stock on December 23, 2025. The transaction, coded as a gift (G), resulted in zero proceeds. This is further detailed by footnote F1, indicating the shares were gifted to a charitable...

This SEC filing (Form 4) details transactions of Horizon Kinetics Holding Corp common stock by several reporting persons, including Maran Partners Fund, LP, Maran Partners GP, LLC, Maran SPV, LP, Maran SPV GP, LLC, Maran Capital Management, LLC, and Daniel J. Roller. On December 23, 2025, Maran Partners Fund, LP acquir...

William B. Horne, a director of Alzamend Neuro, Inc. (ALZN), sold all 3,333 shares of common stock on December 19, 2025, at a price of $2.1178 per share. This transaction resulted in Horne holding zero shares following the sale. The Form 4 filing, signed on December 23, 2025, indicates that Horne is a director of the c...

Howard Carly E, a director at CEA Industries Inc., reported a transaction on October 7, 2025. The transaction involved the vesting of 1,330 restricted stock units (RSUs), which converted into common stock on a one-for-one basis. This vesting is in accordance with the schedule outlined in the Restricted Stock Unit Agree...

This filing details transactions made by Ivan Hyep, Chief Financial Officer of Bicara Therapeutics Inc. On December 22, 2025, Mr. Hyep acquired 9,200 shares of Common Stock under a Rule 10b5-1 trading plan at an average price of $3.7898 per share, increasing his post-transaction holdings to 154,555 shares. Concurrently...

This filing details a transaction by Roemer Alan S., a director at IN8BIO, INC. On December 22, 2025, Mr. S. acquired 36,232 shares of Common Stock at a price of $1.38 per share. Following this transaction, Mr. S. now owns 49,514 shares. It is important to note that the reported share numbers have been adjusted to refl...

This filing details a transaction by Patrick McCall, the Chief Financial Officer of IN8BIO, INC. On December 22, 2025, McCall acquired 7,247 shares of common stock at a price of $1.38 per share. Following this transaction, McCall now owns 9,482 shares. It is important to note that the reported share quantities have bee...

Kate Rochlin, Chief Operating Officer of IN8BIO, INC., reported a transaction on December 22, 2025. She acquired 7,247 shares of Common Stock at a price of $1.38 per share. This transaction was made after a 1-for-30 reverse stock split, which adjusted the reported securities. Following this acquisition, Rochlin directl...

On December 23, 2025, Lisa Utzschneider, Chief Executive Officer and Director of INTEGRAL AD SCIENCE HOLDING CORP., reported several transactions. In a non-derivative transaction, 411,985 shares of Common Stock were disposed of at $10.30 per share, as part of a merger agreement where the company was acquired. This tran...

Jill Putman, a director at Integral Ad Science Holding Corp. (IAS), reported the disposition of 132,355 shares of common stock on December 23, 2025. The shares were sold at a price of $10.30 per share, resulting in a total transaction value of $1,363,256.50. This transaction occurred in connection with a merger agreeme...

Alpana Wegner, Chief Financial Officer of INTEGRAL AD SCIENCE HOLDING CORP. (IAS), reported a disposition of 525,279 shares of common stock on December 23, 2025. The shares were sold at a price of $10.30 per share, resulting in a post-transaction share count of 0. This transaction occurred in connection with a merger, ...

Lord Robert, a director at Integral Ad Science Holding Corp. (IAS), reported a disposition of 29,184 shares of common stock on December 23, 2025, at a price of $10.30 per share. This transaction was executed as part of a merger agreement where the company merged with Igloo Group Parent, Inc. The disposition includes 17...

This filing details a Form 4 submission by Thad Jampol, Chief Product Officer at Intapp, Inc. On December 19, 2025, Jampol acquired 16,787 shares of Intapp Common Stock at a price of $7.45 per share, increasing his direct post-transaction holdings to 902,334 shares. Concurrently, an employee stock option for 16,787 sha...

John A. Kritzmacher, a director at InterDigital, Inc. (IDCC), reported the sale of 1,250 shares of common stock on December 23, 2025. The shares were sold at a price of $331.00 per share, totaling $413,750. This transaction was executed as part of a Rule 10b5-1 trading plan adopted on August 12, 2025. Following the sal...

This Form 4 filing details transactions made by Inukonda Ravi, Chief Financial Officer of DoorDash, Inc. On December 19, 2025, Ravi acquired 800 shares of Class A Common Stock through the exercise of a stock option at a price of $7.66 per share, increasing his post-transaction shares to 185,462. Concurrently, he dispos...

This Form 4 filing details a transaction by Morgan Kathleen A., Chief Legal Officer of Iridium Communications Inc. On December 19, 2025, Ms. Morgan disposed of 974 shares of Common Stock. The transaction, coded as 'F', involved the withholding of shares to cover taxes associated with accelerated vesting upon a qualifie...

This filing details a transaction by Last Timothy James, EVP, Sales & Marketing at Iridium Communications Inc. On December 19, 2025, Mr. James disposed of 974 shares of Common Stock. The transaction code "F" indicates that the shares were withheld to cover taxes associated with the accelerated vesting of restricted sto...

Vincent James O'Neill, Chief Financial Officer of Iridium Communications Inc., reported a transaction on December 19, 2025. The transaction involved the disposal of 1304 shares of Common Stock at a price of $17.04 per share, for a total value of $22,221.60. This transaction was executed under transaction code "F", indi...

Scott Scheimreif, EVP-GOVERNMENT PROGRAMS at Iridium Communications Inc., reported a transaction on December 19, 2025, involving the disposal of 1032 shares of common stock. The shares were disposed of at a price of $17.04 per share, with a total value of $17,575.68. This transaction was conducted under a specific foot...

This filing details transactions made by William Iwaschuk, Co-President and CLO of Cipher Mining Inc., on December 19, 2025. Iwaschuk acquired 917,120 Performance Stock Units (PSUs), which vest in installments starting March 31, 2026, subject to continued service. These PSUs are convertible into Common Stock. Additiona...

Alan Smolinisky, a director at Jack In The Box Inc., reported a transaction involving 20,000 shares of Common Stock acquired at a price of $22.50 per share on December 19, 2025. This transaction resulted in a post-transaction share count of 160,646 shares held indirectly through The Alan Smolinisky Trust. The filing al...

Tina Jones, a director at JAPAN SMALLER CAPITALIZATION FUND INC (JOF), acquired 950 shares of common stock on December 22, 2025. The transaction was made at a price of $10.8003 per share, with a total value of $10,260.285. Following this transaction, Jones directly owns 950 shares of the company's common stock. The fil...

Jeffery A. Liberman, President and COO of ENTRAVISION COMMUNICATIONS CORP, reported a transaction on December 20, 2025, involving 124,303 shares of Class A common stock. The shares were disposed of at a price of $3.18 per share, resulting in 319,100 shares remaining. This transaction represented a withholding of common...